Immune-mediated mechanism in coronavirus fulminant myocarditis
- PMID: 32320031
- PMCID: PMC7188134
- DOI: 10.1093/eurheartj/ehaa333
Immune-mediated mechanism in coronavirus fulminant myocarditis
Comment on
-
Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin.Eur Heart J. 2021 Jan 7;42(2):206. doi: 10.1093/eurheartj/ehaa190. Eur Heart J. 2021. PMID: 32176300 Free PMC article. No abstract available.
References
-
- Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol 2020; doi:10.1001/jamacardio.2020.1286. - PubMed
-
- Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, Levine GN, Narula J, Starling RC, Towbin J, Virmani R; American Heart Association; American College of Cardiology; European Society of Cardiology. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 2007;116:2216–2233. - PubMed
